Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-22-031144
Filing Date
2022-03-07
Accepted
2022-03-07 17:25:48
Documents
1
Group Members
COSMO TECHNOLOGIES LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13G tm227735d1_sc13g.htm SC 13G 58814
  Complete submission text file 0001104659-22-031144.txt   60281
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Subject) CIK: 0001553846 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: SC 13G | Act: 34 | File No.: 005-87280 | Film No.: 22719235
SIC: 2834 Pharmaceutical Preparations

Mailing Address RIVERSIDE II, SIR JOHN ROGERSON'S QUAY DUBLIN L2 2
Business Address RIVERSIDE II, SIR JOHN ROGERSON'S QUAY DUBLIN L2 2 353 1 817 0370
Cosmo Pharmaceuticals N.V. (Filed by) CIK: 0001915527 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13G